2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

 

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer
H

Where Are We Going With Biosimilars in Oncology? Data Based on the New Frontier in HER2+ Tumors - Trastuzumab

By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Hope Rugo
By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Hope Rugo
835 views
September 10, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Biosimilars
17:28

Overview of Biosimilars in Oncology: What Are They and How They Fit …

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

M. Aapro

396 views
19:47

Biosimilars in Supportive Care: Implementation, Safety, Efficacy, an…

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

E. Foreman

23 views
15:44

2019 Overview of Current Guidelines on the Use of Biosimilars

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

H. Dhillon

212 views
21:12

Where Are We Going With Biosimilars in Oncology? Data Based on the N…

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

H. Rugo

835 views